SilcsBio Joins with NIST and Pharma Partner In Validating SILCS Technology for Biologics Formulation

FOR IMMEDIATE RELEASE:   SilcsBio Joins with NIST and Pharma Partner In Validating SILCS Technology for Biologics Formulation   Scientific collaboration demonstrates effective computational method for stabilizing biologic therapeutics such as antibodies   December 16, 2020, Baltimore, MD – SilcsBio, LLC, a technology company that develops and markets software and services for structure-based drug design, today announced members […]

Continue Reading